Teresa E Baker
Overview
Explore the profile of Teresa E Baker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
131
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Young M, Holder K, Baker T, Kauffman R
Case Rep Womens Health
. 2023 Jan;
37:e00478.
PMID: 36636108
A 60-year-old woman was referred for progressive and severe vulvovaginal pain characterized by erosions and Wickham's stria for the past 7 months. Her condition had not responded to oral fluconazole,...
2.
Baker T, Croop R, Kamen L, Price P, Stock D, Ivans A, et al.
Breastfeed Med
. 2022 Jan;
17(3):277-282.
PMID: 35049333
Investigate whether rimegepant-an oral small molecule calcitonin gene-related peptide receptor antagonist for the treatment of migraine-is excreted in human milk after a single 75 mg dose and characterize its concentration-time...
3.
Cooper S, Felkins K, Baker T, Hale T
J Hum Lact
. 2015 Feb;
31(2):237-9.
PMID: 25691380
High-dose intravenous methylprednisolone, a glucocorticoid with powerful anti-inflammatory activities, has become increasingly important in treating acute relapses of multiple sclerosis (MS). This is a case report of a 36-year-old lactating...
4.
Baker T, Cooper S, Kessler L, Hale T
J Hum Lact
. 2015 Jan;
31(2):233-6.
PMID: 25586712
Natalizumab (Tysabri) is a recombinant humanized antibody to α4-integrin that is approved by the Food and Drug Administration for the treatment of multiple sclerosis (MS) and Crohn disease. This is...
5.
Griffin S, Milla M, Baker T, Liu T, Wang H, Hale T
J Hum Lact
. 2012 Oct;
28(4):457-9.
PMID: 23087196
Carboplatin is an alkylating agent that is FDA approved for the treatment of advanced ovarian cancer. Paclitaxel is a plant taxane mitotic inhibitor approved for primary or salvage treatment of...
6.
Hale T, Siddiqui A, Baker T
Breastfeed Med
. 2011 Oct;
7(2):123-5.
PMID: 21988602
Aim: This study determined the transfer of intramuscular interferon β-1a into human milk and provides an estimate of infant exposure to this antiviral in six women chronically receiving intramuscular interferon...
7.
Lipoprotein profiles in Mexican American and non-Hispanic white women with polycystic ovary syndrome
Kauffman R, Baker T, Graves-Evenson K, Baker V, Castracane V
Fertil Steril
. 2011 Oct;
96(6):1503-7.
PMID: 21982731
Objective: To compare lipid profiles between Mexican American and non-Hispanic white women with polycystic ovary syndrome (PCOS). Design: Cross-sectional analysis using the Strengthening the Reporting of Observational Studies in Epidemiology...
8.
Glass T, Tucker K, Stewart R, Baker T, Kauffman R
J Womens Health (Larchmt)
. 2010 Aug;
19(9):1659-63.
PMID: 20799897
Background: Adolescents consistently demonstrate the lowest rates of breastfeeding among women of reproductive age despite well-documented benefits of breastfeeding. In Amarillo, Texas, a medium-sized community with a perennially high teen...
9.
Kauffman R, Baker T, Baker V, Kauffman M, Castracane V
Gynecol Endocrinol
. 2009 Dec;
26(1):39-46.
PMID: 20001571
Objective: To characterise the metabolic profile of women with polycystic ovary syndrome (PCOS) and non-alcoholic fatty liver disease (NAFLD) and to determine whether circulating androgens differ in PCOS women with...
10.
Kauffman R, Baker T, Baker V, DiMarino P, Castracane V
Am J Obstet Gynecol
. 2008 Mar;
198(6):670.e1-7.
PMID: 18355776
Objective: The Rotterdam criteria extend the phenotypic spectrum of polycystic ovary syndrome (PCOS). We characterized endocrine and metabolic differences among women meeting the National Institutes of Health (NIH) definition for...